1. Home
  2. List
Reference Patent

Reference - List

  • 99 Hits
  • Search Condition : Filter (MeSH = Neoplasms / genetics)
Species Resource Title
Human and Animal Cells HuH-6(RCB1367) Cysteamine dioxygenase (ADO) governs cancer cell mitochondrial redox homeostasis through proline metabolism.
Human and Animal Cells HeLa(RCB0007) , 293T(RCB2202) Pax5 mediates the transcriptional activation of the CD81 gene.
Human and Animal Cells TT1TKB(RCB1185) Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis.
Drosophila 4005R-2 Blockade of Crk eliminates Yki/YAP-activated tumors via JNK-mediated apoptosis in Drosophila.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Development of Human CBF1-Targeting Single-Stranded DNA Aptamers with Antiangiogenic Activity In Vitro.
Mice RBRC02759 Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation.
Human and Animal Cells HUDEP-2(RCB4557) Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.
Human and Animal Cells KP4(RCB1005) MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage.
Human and Animal Cells II-18(RCB2093) Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors.
Human and Animal Cells EBC-1(RCB1965) PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.
Human and Animal Cells NIH3T3-3-4(RCB1862) Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
Human and Animal Cells A549(RCB0098) , HeLa(RCB0007) DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency.
Human and Animal Cells EBC-1(RCB1965) , A549 , HSC-4(RCB1902) , LU65(RCB1967) A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.
Yeast FY11064(MY3141) , FY10067(MY2167) Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.
Human and Animal Cells C2C12(RCB0987) , B16F10(RCB2630) Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors.
Human and Animal Cells Ba/F3 Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
Human and Animal Cells B16F10(RCB2630) Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.
Human and Animal Cells human iPS Robust cancer-specific gene expression by a novel cassette with hTERT and CMV promoter elements.
Human and Animal Cells MKN45(RCB1001) , MKN74(RCB1002) Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil.
Human and Animal Cells Ba/F3 Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers.